Following completion of a MSc in Public Health from the University of Bristol, I joined the Oncology Clinical Trials Office (OCTO) in December 2017 as a Clinical Trial Support Officer. After spending a year at an international CRO in 2019 gaining experience on industry-led research, I returned to OCTO working in the Pharmacovigilance Team across all safety reporting trials.
In September 2021 I started as a Trial Manager working on IPI-GLIO, CEeDD and IMAGO.
IPI-GLIO: A Phase II, Open Label, Randomised Study of Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma.
CEeDD: A First-in Human Clinical Investigation of Cavitation Enhanced Drug Delivery to Solid Tumours by co-Administration of the Sonosensitive Particles and Application of Extracorporeal Ultrasound in Patients with Colorectal Metastases to the Liver
IMAGO: A single arm exploratory study examining the feasibility of imaging glioblastoma pH using CEST MRI